Showing 85–104 of 104 results
TAFINLAR is a targeted therapy designed to help address cancers driven by specific BRAF gene mutations. By targeting abnormal signaling pathways involved in tumor growth, TAFINLAR® plays an important role in personalized treatment approaches for eligible patients.
Temoside 100 Capsule is used in the treatment of a specific type of cancer of the brain. It is used to treat brain tumors if they return or get worse after standard treatment.
Temoside 250 Capsule is used in the treatment of a specific type of cancer of the brain. It is used to treat brain tumors if they return or get worse after standard treatment.
Tipanat Tablet (Trifluridine + Tipiracil) Overview Tipanat is an anticancer medication containing a combination of Trifluridine and Tipiracil. It is primarily used in the treatment of advanced or metastatic colorectal cancer and certain types of advanced gastric cancer in patients who have previously received other cancer treatments. The medicine works by slowing or stopping the…
Tipanat is an anticancer medication containing a combination of Trifluridine and Tipiracil. It is primarily used in the treatment of advanced or metastatic colorectal cancer and certain types of advanced gastric cancer in patients who have previously received other cancer treatments.
Ujvira is an anti-cancer medicine for the treatment of HER2-positive cancers. It contains trastuzumab-based therapy and is primarily used in patients with HER2-positive breast cancer.
Veenat is a prescription anticancer medicine containing imatinib mesylate, a targeted therapy classified as a tyrosine kinase inhibitor (TKI). It is manufactured by Natco Pharma Veenat works by blocking abnormal proteins that promote the growth and multiplication of cancer cells.
Veenat is a prescription anticancer medicine containing imatinib mesylate, a targeted therapy classified as a tyrosine kinase inhibitor (TKI). It is manufactured by Natco Pharma and is available in different strengths, including 100 mg and 400 mg formulations. Veenat works by blocking abnormal proteins that promote the growth and multiplication of cancer cells.
Vinlon 1mg Injection is an anti-cancer medication used in the treatment of breast cancer, non-small cell lung cancer, pancreatic cancer, kidney cancer, blood cancer, multiple myeloma, lymphomas and bone cancer.
Votrient 200mg Tablet is a protein kinase inhibitor used in the treatment of kidney cancer and soft tissue sarcoma.
Votrient 400mg Tablet is a protein kinase inhibitor used in the treatment of kidney cancer and soft tissue sarcoma.
Xalkori is the brand name for crizotinib, an oral targeted therapy developed to treat certain cancers driven by specific genetic alterations.
XOLAIR® (omalizumab) is a prescription biologic medicine designed to target immunoglobulin E (IgE), a key driver of allergic responses. By reducing the activity of IgE, XOLAIR helps address the underlying cause of certain allergic and inflammatory conditions, supporting better disease control and improved quality of life.
XTANDI® (enzalutamide) is an oral androgen receptor inhibitor used in the treatment of advanced prostate cancer. It works by blocking the activity of androgens, such as testosterone, which can stimulate the growth of prostate cancer cells.
Xylutide 40mg Capsule is used in the treatment of cancer of the prostate gland. It may be also used to treat other conditions, as determined by the doctor. It works by blocking the effects of male hormones such as testosterone.
YERVOY® (ipilimumab) is an immunotherapy medicine used to treat several types of cancer. It belongs to a class of drugs known as immune checkpoint inhibitors and works by helping the body’s immune system recognize and attack cancer cells.
Zejula (niraparib) is an oral prescription medication used in the treatment of certain types of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
ZEPZELCA is a prescription medication used in adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
ZOLINZA (vorinostat) is an orally administered histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent, or recurrent disease following two prior systemic therapies.